XBiotech Inc.
XBIT
$2.32
-$0.09-3.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 147.37M | 152.94M | 155.90M | 172.68M | 183.12M |
| Total Receivables | 525.00K | 638.00K | 638.00K | 858.00K | 871.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.06M | 1.31M | 1.15M | 1.03M | 1.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 148.95M | 154.89M | 157.69M | 174.57M | 185.03M |
|
|
|||||
| Total Current Assets | 148.95M | 154.89M | 157.69M | 174.57M | 185.03M |
| Net Property, Plant & Equipment | 23.47M | 23.79M | 24.18M | 24.53M | 24.82M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 172.42M | 178.68M | 181.86M | 199.09M | 209.85M |
|
|
|||||
| Total Accounts Payable | 1.04M | 1.43M | 1.10M | 2.22M | 1.51M |
| Total Accrued Expenses | 2.42M | 2.41M | 4.30M | 2.63M | 4.49M |
| Short-term Debt | -- | -- | -- | 10.25M | 10.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 100.00K | 16.00K | 7.00K | -- | -- |
| Total Other Current Liabilities | 100.00K | 16.00K | 7.00K | -- | -- |
| Total Current Liabilities | 3.57M | 3.86M | 5.41M | 15.11M | 15.99M |
|
|
|||||
| Total Current Liabilities | 3.57M | 3.86M | 5.41M | 15.11M | 15.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 10.25M | 10.00M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.78M | 1.76M | 1.74M | 1.72M | 1.74M |
| Total Liabilities | 5.34M | 5.62M | 7.15M | 16.83M | 17.74M |
|
|
|||||
| Common Stock & APIC | 276.57M | 276.54M | 276.43M | 273.11M | 272.44M |
| Retained Earnings | -109.49M | -103.48M | -101.72M | -90.84M | -80.33M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 167.08M | 173.06M | 174.71M | 182.27M | 192.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 167.08M | 173.06M | 174.71M | 182.27M | 192.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 167.08M | 173.06M | 174.71M | 182.27M | 192.12M |
|
|
|||||